Structure

InChI Key WOLHOYHSEKDWQH-UHFFFAOYSA-N
Smile Cl.NC12CC3CC(CC(C3)C1)C2
InChI
InChI=1S/C10H17N.ClH/c11-10-4-7-1-8(5-10)3-9(2-7)6-10;/h7-9H,1-6,11H2;1H

Physicochemical Descriptors

Property Name Value
Molecular Formula C10H18ClN
Molecular Weight 187.71
AlogP 1.91
Hydrogen Bond Acceptor 1.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 0.0
Polar Surface Area 26.02
Molecular species BASE
Aromatic Rings 0.0
Heavy Atoms 11.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Glutamate [NMDA] receptor antagonist DailyMed Wikipedia

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Influenza, Human 4 D007251 FDA
Severe Acute Respiratory Syndrome 3 D045169 ClinicalTrials
Multiple Sclerosis 3 D009103 ClinicalTrials
Brain Injuries 2 D001930 ClinicalTrials
Hepatitis C 2 D006526 ClinicalTrials
Psychotic Disorders 1 D011618 ClinicalTrials
Mood Disorders 1 D019964 ClinicalTrials
Schizophrenia 1 D012559 ClinicalTrials

Related Entries

Parent

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Nervous system disorders
23.09
Psychiatric disorders
16.11
General disorders and administration site conditions
13.53
Injury, poisoning and procedural complications
7.67
Gastrointestinal disorders
6.14
Cardiac disorders
5.31
Musculoskeletal and connective tissue disorders
4.71
Vascular disorders
3.93
Respiratory, thoracic and mediastinal disorders
3.21
Skin and subcutaneous tissue disorders
2.8
Eye disorders
2.63
Metabolism and nutrition disorders
2.57

Cross References

Resources Reference
ChEBI 2619
ChEMBL CHEMBL1569
EPA CompTox DTXSID50874031
FDA SRS M6Q1EO9TD0
Guide to Pharmacology 4128
KEGG C07939
PDB 308
PubChem 64150
SureChEMBL SCHEMBL40713
ZINC ZINC00968256